DE69313534T2 - Digitoxigenin und Dihydrodigitoxigenin 3-beta-Derivate und pharmazeutische Präparate davon, zur Behandlung von hypertonie - Google Patents

Digitoxigenin und Dihydrodigitoxigenin 3-beta-Derivate und pharmazeutische Präparate davon, zur Behandlung von hypertonie

Info

Publication number
DE69313534T2
DE69313534T2 DE69313534T DE69313534T DE69313534T2 DE 69313534 T2 DE69313534 T2 DE 69313534T2 DE 69313534 T DE69313534 T DE 69313534T DE 69313534 T DE69313534 T DE 69313534T DE 69313534 T2 DE69313534 T2 DE 69313534T2
Authority
DE
Germany
Prior art keywords
dihydrodigitoxigenin
digitoxigenin
hypertension
treatment
pharmaceutical preparations
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69313534T
Other languages
English (en)
Other versions
DE69313534D1 (de
Inventor
Piero Melloni
Luigi Bernardi
Patrizia Ferrari
Mauro Gobbini
Marco Torri
Loredana Valentino
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sigma Tau Industrie Farmaceutiche Riunite SpA
Original Assignee
Sigma Tau Industrie Farmaceutiche Riunite SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sigma Tau Industrie Farmaceutiche Riunite SpA filed Critical Sigma Tau Industrie Farmaceutiche Riunite SpA
Priority to DE69313534T priority Critical patent/DE69313534T2/de
Publication of DE69313534D1 publication Critical patent/DE69313534D1/de
Application granted granted Critical
Publication of DE69313534T2 publication Critical patent/DE69313534T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J19/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 by a lactone ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J31/00—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring
    • C07J31/003—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring the S atom directly linked to a ring carbon atom of the cyclopenta(a)hydrophenanthrene skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
    • C07J41/0055—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 the 17-beta position being substituted by an uninterrupted chain of at least three carbon atoms which may or may not be branched, e.g. cholane or cholestane derivatives, optionally cyclised, e.g. 17-beta-phenyl or 17-beta-furyl derivatives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
    • C07J41/0088—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 containing unsubstituted amino radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J43/00—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C07J43/003—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton not condensed
DE69313534T 1992-07-01 1993-06-16 Digitoxigenin und Dihydrodigitoxigenin 3-beta-Derivate und pharmazeutische Präparate davon, zur Behandlung von hypertonie Expired - Fee Related DE69313534T2 (de)

Priority Applications (1)

Application Number Priority Date Filing Date Title
DE69313534T DE69313534T2 (de) 1992-07-01 1993-06-16 Digitoxigenin und Dihydrodigitoxigenin 3-beta-Derivate und pharmazeutische Präparate davon, zur Behandlung von hypertonie

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE4221635A DE4221635C1 (de) 1992-07-01 1992-07-01 3beta-Digitoxigenin- und 3beta-Dihydrodigitoxigenin-Derivate
DE69313534T DE69313534T2 (de) 1992-07-01 1993-06-16 Digitoxigenin und Dihydrodigitoxigenin 3-beta-Derivate und pharmazeutische Präparate davon, zur Behandlung von hypertonie

Publications (2)

Publication Number Publication Date
DE69313534D1 DE69313534D1 (de) 1997-10-09
DE69313534T2 true DE69313534T2 (de) 1998-02-19

Family

ID=6462264

Family Applications (2)

Application Number Title Priority Date Filing Date
DE4221635A Expired - Fee Related DE4221635C1 (de) 1992-07-01 1992-07-01 3beta-Digitoxigenin- und 3beta-Dihydrodigitoxigenin-Derivate
DE69313534T Expired - Fee Related DE69313534T2 (de) 1992-07-01 1993-06-16 Digitoxigenin und Dihydrodigitoxigenin 3-beta-Derivate und pharmazeutische Präparate davon, zur Behandlung von hypertonie

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DE4221635A Expired - Fee Related DE4221635C1 (de) 1992-07-01 1992-07-01 3beta-Digitoxigenin- und 3beta-Dihydrodigitoxigenin-Derivate

Country Status (8)

Country Link
US (1) US5478817A (de)
EP (1) EP0576913B1 (de)
JP (1) JPH0665285A (de)
AT (1) ATE157670T1 (de)
DE (2) DE4221635C1 (de)
DK (1) DK0576913T3 (de)
ES (1) ES2106922T3 (de)
GR (1) GR3024707T3 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7361478B2 (en) * 2001-11-20 2008-04-22 Allergan, Inc. High-throughput screen for identifying selective persistent sodium channels channel blockers
US20040064050A1 (en) * 2002-09-20 2004-04-01 Jun Liu System and method for screening tissue

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2004543A1 (de) * 1970-02-02 1971-08-12 Knoll Ag, Chemische Fabriken, 6700 Ludwigshafen Alkoxymethylather von herzwirksamen Steroiden
DE2517293C2 (de) * 1975-04-18 1984-02-16 Knoll Ag, 6700 Ludwigshafen Neue Cardenolid-β-Glykoside, ihre Herstellung und Verwendung
FR2310766A1 (fr) * 1975-05-16 1976-12-10 Nativelle Sa Ets Derives de cardenolides, procede de preparation et application a titre de medicament
DE2833472A1 (de) * 1978-07-29 1980-03-06 Beiersdorf Ag Digitoxigenin-monodigitoxosid-derivate und verfahren zu ihrer herstellung
US4259240A (en) * 1979-09-28 1981-03-31 Advance Biofactures Corporation Synthesis of furyl intermediates, and cardenolides and their isomers prepared therefrom
GB8600491D0 (en) * 1986-01-09 1986-02-12 Erba Farmitalia Aminoglycoside norcholanic acid derivatives
GB8916635D0 (en) * 1989-07-20 1989-09-06 Erba Carlo Spa Cardanolactam derivatives

Also Published As

Publication number Publication date
GR3024707T3 (en) 1997-12-31
EP0576913A2 (de) 1994-01-05
ATE157670T1 (de) 1997-09-15
DE69313534D1 (de) 1997-10-09
JPH0665285A (ja) 1994-03-08
DE4221635C1 (de) 1994-05-05
EP0576913B1 (de) 1997-09-03
DK0576913T3 (da) 1997-11-03
US5478817A (en) 1995-12-26
EP0576913A3 (de) 1995-04-19
ES2106922T3 (es) 1997-11-16

Similar Documents

Publication Publication Date Title
DE69033538D1 (de) Verfahren zur Herstellung der 1,2-Doppelbindung von 4-aza-Steroiden und kristallinen Proscor(R) und pharmazeutische Präparate davon
DE68923819D1 (de) Verwendung von gamma-Hydroxy-Buttersäuresalzen zur Herstellung von pharmazeutischen Zusammensetzungen zur Verwendung bei der Behandlung von Alkoholismus und die hergestellten Zusammensetzungen.
DE3688114D1 (de) Inklusionskomplexe von 7-isopropoxy-isoflavon mit cyclodextrinen, verfahren zu deren herstellung und diese inklusionskomplexe enthaltende pharmazeutische praeparate.
NO890259L (no) Fremgangsmaate for fremstilling av terapeutisk aktive etylfenoksyacetamider.
DE69124769T2 (de) Verfahren zur Herstellung von (1'R,3S)-3-(1'-hydroxy-ethyl)-Azetidin-2-on und deren Derivaten
DE3878313D1 (de) Taurohyodeoxycholsaeure zur behandlung von gallenwegssteinen und gallenstoerungen.
DK0579996T3 (da) 5,10-Methylentetrahydrofolsyrecyclodextrin-inklusionsforbindelser
NO171909C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 1,4-dihydropyridinderivater
ATE151774T1 (de) Cyclopentanperhydrophenanthren-17-beta-(3-furyl - 3-derivate und pharmazeutische präparate davon, zur behandlung von kardiovaskulär-erkrankungen
ES2060293T3 (es) Nueva sustancia antiulcerosa.
ATE218856T1 (de) Aminotetralinderivat zur behandlung von herzkreislauferkrankung
ATE5256T1 (de) Phenylpiperazinderivate von 1,3,4oxadiazolylphenolen, ihre herstellung und diese enthaltende therapeutische mittel.
ATE157670T1 (de) Digitoxigenin und dihydrodigitoxigenin 3-beta- derivate und pharmazeutische präparate davon, zur behandlung von hypertonie
IT8721436A0 (it) "derivati di 2,3,4,5,6,7 esaidro 2,7 metano 1,5 benzossazonina (rispettivamente 1,4 benzossazonina), procedimento per la loro preparazione e prodotti medicinali che contengono questi composti.
DE59200566D1 (de) Aryl-Chinolyl-substituierte 1,4-Dihydropyridin-dicarbonsäurederivate, Verfahren zu ihrer Herstellung und ihre Verwendung in Arzneimitteln.
IT8720271A0 (it) Nuovi derivati dell'ergolene, composizioni farmaceutiche che licontengono e procedimento per lapreparazione dei medesimi.
ATE191462T1 (de) Im kardiovaskulären system aktive seco-d- steroide, verfahren zu deren herstellung und diese enthaltende pharmazeutische zubereitungen
ATA901889A (de) Verfahren zur herstellung von wasserlöslichem primycin und seinen komponenten sowie von diese enthaltenden pharmazeutischen präparaten
EP0324348A3 (de) Piperidincarboxamid-Derivate zur Behandlung von Bradycardien und Bradyarrhythmien
IL79944A (en) N-substituted 3,4-dihydropyrimidine derivatives and pharmaceutical compositions for treating disorders of the cardiovascular system
ATE88342T1 (de) Pharmazeutische zubereitungen zur behandlung der psoriasis, psoriatischen arthritis, neurodermitis und enteritis regionalis crohn.
ATE59776T1 (de) Pharmazeutische zusammensetzung und behandlung.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee